Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016
| Autor: | Ulrich Klein, Jill R. Thomson, Miklós Gyuranecz, Roger D. Ayling, Myriam Youala, Andrew Pridmore, Dominiek Maes, Farid El Garch, Hilde Moyaert, Shabbir Simjee, Anno de Jong |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Veterinary medicine
Swine Tiamulin Microbial Sensitivity Tests IN-VITRO SUSCEPTIBILITIES Tylosin Antimicrobial susceptibility Microbiology RECOMMENDATIONS 03 medical and health sciences chemistry.chemical_compound Porcine enzootic pneumonia Mycoplasma hyopneumoniae Marbofloxacin medicine Animals PIGS Tulathromycin Mycoplasma Infections Veterinary Sciences BOVIS 030304 developmental biology Minimal inhibitory concentrations 0303 health sciences Surveillance General Veterinary biology 030306 microbiology Broth microdilution Spiramycin Biology and Life Sciences General Medicine biology.organism_classification Anti-Bacterial Agents Europe MACROLIDES chemistry Animals Domestic Epidemiological Monitoring ACQUIRED-RESISTANCE medicine.drug |
| Zdroj: | VETERINARY MICROBIOLOGY |
| ISSN: | 1873-2542 0378-1135 |
| Popis: | Mycoplasma hyopneumoniae is the causative agent of porcine enzootic pneumonia, a chronic respiratory disease, causing significant economic losses. Results from the 2015-2016 MycoPath pan-European antimicrobial susceptibility monitoring survey of M. hyopneumoniae are presented. In total, 147 M. hyopneumoniae porcine isolates from Belgium, France, Germany, Great Britain, Hungary, Italy, and Spain were tested. One isolate per farm was retained from pigs that had not been recently treated with antimicrobial agents. The minimal inhibitory concentration (MIC) of 13 antimicrobial agents was determined in a central laboratory using a broth microdilution method, with Friis Medium, incubated at 35 +/- 1 degrees C for 5-12 days. M. hyopneumoniae NCTC 10110 was used as Quality Control. MIC50/MIC90 (mg/L) values were: enrofloxacin 0.06/1; marbofloxacin 0.06/2; spiramycin 0.06/0.25; tulathromycin |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect